Basel, 3 February 2021
We are pleased to launch the Call for Abstracts for the Medtech & Pharma Platform 2021 Annual Conference (MPP2021) to be held on 21 October 2021 in Basel.
The theme for MPP2021 is “Achieving agility to foster innovation and bring value to patients”. Taking stock of the increasing use of new technologies for medicinal products and the trend towards digitalization of the healthcare sector, this conference will be the opportunity for various stakeholders to exchange ideas and experience, and to foster the development of innovative healthcare products and develop personalized healthcare for patients.
The categories for MPP2021 abstract submissions address six major areas that present both opportunities and challenges for combined products. These categories explore how the medtech, pharma and software industries can reach the objective of “achieving a supporting regulatory framework” for combined products, tackle the question “how can connected and digital healthcare create value to the patient”, explore ways of “accelerating patient access to innovative products”, analyze the challenges and opportunities for “new technologies in innovative combined products” and for “facilitating personalized healthcare using combined products”, and discuss how to achieve agility through “new ways of collaboration for combined products”.
Full details on Call for Abstracts categories, sub-topics of interest and the submission form can be found on the MPP Call for Abstracts webpage. Deadline for abstract submission is 17 March 2021. Abstracts will be assessed and selected by the MPP2021 Program Committee, comprising medical device experts from leading medtech and pharma companies.